ZA956986B - Methods of inhibiting viral replication. - Google Patents

Methods of inhibiting viral replication.

Info

Publication number
ZA956986B
ZA956986B ZA9506986A ZA956986A ZA956986B ZA 956986 B ZA956986 B ZA 956986B ZA 9506986 A ZA9506986 A ZA 9506986A ZA 956986 A ZA956986 A ZA 956986A ZA 956986 B ZA956986 B ZA 956986B
Authority
ZA
South Africa
Prior art keywords
viral replication
inhibiting viral
methods
image
hexamethyleneamino
Prior art date
Application number
ZA9506986A
Other languages
English (en)
Inventor
Andrew Lawrence Glasebrook
David Lynn Phillips
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA956986B publication Critical patent/ZA956986B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
ZA9506986A 1994-08-22 1995-08-21 Methods of inhibiting viral replication. ZA956986B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/294,171 US5494920A (en) 1994-08-22 1994-08-22 Methods of inhibiting viral replication

Publications (1)

Publication Number Publication Date
ZA956986B true ZA956986B (en) 1997-02-21

Family

ID=23132219

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9506986A ZA956986B (en) 1994-08-22 1995-08-21 Methods of inhibiting viral replication.

Country Status (15)

Country Link
US (1) US5494920A (xx)
EP (1) EP0771200B1 (xx)
JP (1) JPH10504572A (xx)
AT (1) ATE189601T1 (xx)
AU (1) AU3408795A (xx)
CA (1) CA2198122A1 (xx)
DE (1) DE69515038T2 (xx)
DK (1) DK0771200T3 (xx)
ES (1) ES2141957T3 (xx)
GR (1) GR3033269T3 (xx)
IL (1) IL115014A0 (xx)
MX (1) MX9701329A (xx)
PT (1) PT771200E (xx)
WO (1) WO1996005830A1 (xx)
ZA (1) ZA956986B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242199B1 (en) 1995-12-13 2001-06-05 Merck & Co., Inc. Assays for growth hormone secretagogue receptors
US6531314B1 (en) 1996-12-10 2003-03-11 Merck & Co., Inc. Growth hormone secretagogue receptor family
US6458811B1 (en) * 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
EP0910369B1 (en) * 1996-03-26 2010-04-21 Eli Lilly And Company Benzothiophenes, formulations containing same, and methods
ATE301129T1 (de) 1999-05-04 2005-08-15 Strakan Int Ltd Androgen glykoside und die androgenische aktivität davon
UA87854C2 (xx) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-бензил)-2-фенілбутанаміди як модулятори рецептора андрогену$n-(2-бензил)-2-фенилбутанамиды как модуляторы рецептора андрогена
EP1819827B1 (en) * 2004-12-08 2010-08-11 Cedars-Sinai Medical Center Methods for diagnosis of crohn's disease
US20100021917A1 (en) * 2007-02-14 2010-01-28 Cedars-Sinai Medical Center Methods of using genes and genetic variants to predict or diagnose inflammatory bowel disease
US20100190162A1 (en) * 2007-02-26 2010-07-29 Cedars-Sinai Medical Center Methods of using single nucleotide polymorphisms in the tl1a gene to predict or diagnose inflammatory bowel disease
US20100015156A1 (en) * 2007-03-06 2010-01-21 Cedars-Sinai Medical Center Diagnosis of inflammatory bowel disease in children
WO2008116150A2 (en) 2007-03-21 2008-09-25 Cedars-Sinai Medical Center Ileal pouch-anal anastomosis (ipaa) factors in the treatment of inflammatory bowel disease
WO2008134569A2 (en) * 2007-04-26 2008-11-06 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease in the puerto rican population
EP2155769B1 (en) * 2007-05-04 2012-06-27 Katholieke Universiteit Leuven KU Leuven Research & Development Tissue degeneration protection
US20100144903A1 (en) * 2007-05-04 2010-06-10 Cedars-Sinai Medical Center Methods of diagnosis and treatment of crohn's disease
US20110177969A1 (en) * 2008-10-01 2011-07-21 Cedars-Sinai Medical Center The role of il17rd and the il23-1l17 pathway in crohn's disease
US20110189685A1 (en) * 2008-10-22 2011-08-04 Cedars-Sinai Medical Center Methods of using jak3 genetic variants to diagnose and predict crohn's disease
WO2010062960A2 (en) 2008-11-26 2010-06-03 Cedars-Sinai Medical Center METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
US9580752B2 (en) 2008-12-24 2017-02-28 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy
WO2013190520A2 (en) 2012-06-22 2013-12-27 The General Hospital Corporation Gh-releasing agents in the treatment of vascular stenosis and associated conditions
BR112015024752A2 (pt) 2013-03-27 2017-07-18 Cedars Sinai Medical Center mitigação e reversão da fibrose e inflamação através da inibição da função de tl1a e vias de sinalização relacionadas
WO2015010108A1 (en) 2013-07-19 2015-01-22 Cedars-Sinai Medical Center Signature of tl1a (tnfsf15) signaling pathway
EP3148587B1 (en) 2014-05-30 2021-02-24 Pfizer Inc Carbonitrile derivatives as selective androgen receptor modulators
US11186872B2 (en) 2016-03-17 2021-11-30 Cedars-Sinai Medical Center Methods of diagnosing inflammatory bowel disease through RNASET2
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体

Also Published As

Publication number Publication date
MX9701329A (es) 1997-05-31
EP0771200B1 (en) 2000-02-09
DE69515038D1 (de) 2000-03-16
WO1996005830A1 (en) 1996-02-29
ATE189601T1 (de) 2000-02-15
CA2198122A1 (en) 1996-02-29
EP0771200A1 (en) 1997-05-07
US5494920A (en) 1996-02-27
IL115014A0 (en) 1995-12-08
DK0771200T3 (da) 2000-05-15
EP0771200A4 (en) 1997-09-10
GR3033269T3 (en) 2000-09-29
ES2141957T3 (es) 2000-04-01
PT771200E (pt) 2000-07-31
AU3408795A (en) 1996-03-14
JPH10504572A (ja) 1998-05-06
DE69515038T2 (de) 2000-06-29

Similar Documents

Publication Publication Date Title
GR3033269T3 (en) Methods of inhibiting viral replication
MX9701360A (es) Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion.
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
MX9701334A (es) Metodos para inhibir la degeneracion de protesis oseas.
MX9709466A (es) Medicamento para inhibir el melanoma.
MX9701333A (es) Metodos para inhibir el daño neuronal.
MX9702148A (es) Metodos para inhibir la mitosis endometrial.
MX9701327A (es) Metodos para inhibir el cancer endometrial.
IL115016A0 (en) Methods for bone healing and fracture repair
MX9701359A (es) Metodos para la inhibicion de la hiperplasia endometrial primaria.
MX9701331A (es) Metodos para mantener los dientes y los huesos bucales.
MX9709536A (es) Metodo para reducir el factor de transcripcion bef-1.
MX9709651A (es) Metodos para modulacion del factor de transcripcion nf-kb.
MX9705940A (es) Metodos y composiciones para inhibir los efectos de la interleucina 6.
MX9705215A (es) Uso de 2-fenil-3-aroilbenzotiofenos para inhibir los efectos de la hormona del crecimiento.
IL115023A0 (en) Methods of reducing scarring in wound healing
MX9705537A (es) Metodos y composiciones para inhibir el efecto de los estrogenos del medio ambiente.
MX9706072A (es) Metodos de inhibicion de la adhesion celula-celula.
MX9706520A (es) Metodos para inhibir el cancer de ovario.
MX9702861A (es) Metodo para inhibir las condiciones asociadas con la bradicinina.
MX9702853A (es) Metodos para inhibir condiciones asociadas con el neuropeptido "y".
MX9705697A (es) Metodos para reducir los niveles de calcio del suero.